Inventor
BAADSGAARD OLE
DK31 patents
⚠️ This page may combine multiple inventors who share the name “BAADSGAARD OLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
16 patentsUS7153507B2Dec 26, 2006
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS367 citations98
US7595378B2Sep 29, 2009
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS64 citations97
US7438907B2Oct 21, 2008
Human monoclonal antibodies against CD25
GENMAB AS50 citations95
US7282568B2Oct 16, 2007
Human monoclonal antibodies against interleukin 8 (IL-8)
GENMAB AS39 citations95
US7247304B2Jul 24, 2007
Methods of treating using anti-IL-15 antibodies
GENMAB AS21 citations90
US7329405B2Feb 12, 2008
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS11 citations83
US9714297B2Jul 25, 2017
Human antibodies against tissue factor and methods of use thereof
GENMAB AS9 citations80
US7622559B2Nov 24, 2009
Human monoclonal antibodies against interleukin 8 (IL-8)
GENMAB AS7 citations73
US11046771B2Jun 29, 2021
Monoclonal antibodies against HER2
GENMAB AS2 citations72
US9598493B2Mar 21, 2017
Human monoclonal antibodies against CD25
GENMAB AS3 citations72
US7585961B2Sep 8, 2009
Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
GENMAB AS5 citations72
US11091553B2Aug 17, 2021
Monoclonal antibodies against HER2
GENMAB AS1 citations61
US10793640B2Oct 6, 2020
Monoclonal antibodies against HER2 epitope
GENMAB AS1 citations61
US7597892B2Oct 6, 2009
Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
GENMAB AS1 citations61
US9458236B2Oct 4, 2016
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS2 citations60
US10703818B2Jul 7, 2020
Human monoclonal antibodies against CD25
GENMAB AS0 citations51
TEELING JESSICA
3 patentsUS8529902B2Sep 10, 2013
Human monoclonal antibodies against CD20
TEELING JESSICA36 citations92
US8603469B2Dec 10, 2013
Methods of treating cancer with human monoclonal antibodies against interleukin 8
TEELING JESSICA5 citations82
US8105588B2Jan 31, 2012
Human monoclonal antibodies against interleukin 8 (IL-8)
TEELING JESSICA7 citations82
CORMORANT PHARMACEUTICALS AB
3 patentsUS11339215B2May 24, 2022
Methods of treating cancer with human monoclonal antibodies against interleukin 8 (IL-8)
CORMORANT PHARMACEUTICALS AB4 citations82
US10253093B2Apr 9, 2019
Human monoclonal antibodies against interleukin 8 (IL-8)
CORMORANT PHARMACEUTICALS AB2 citations71
US10066012B2Sep 4, 2018
Human monoclonal antibodies against interleukin 8 (IL-8)
CORMORANT PHARMACEUTICALS AB2 citations71